{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:14:58Z","timestamp":1772590498767,"version":"3.50.1"},"reference-count":138,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1016\/j.mcna.2009.03.009","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T09:19:16Z","timestamp":1246612756000},"page":"819-836","source":"Crossref","is-referenced-by-count":50,"title":["Hepatic Encephalopathy: Pathophysiology and Emerging Therapies"],"prefix":"10.1016","volume":"93","author":[{"given":"Vinay","family":"Sundaram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obaid S.","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2009.03.009_bib1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1053\/jhep.2002.31250","article-title":"Hepatic encephalopathy\u2014definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998","volume":"35","author":"Ferenci","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.mcna.2008.03.009","article-title":"Hepatic encephalopathy","volume":"92","author":"Munoz","year":"2008","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.mcna.2009.03.009_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/gut.2007.122176","article-title":"Pathogenetic mechanisms of hepatic encephalopathy","volume":"57","author":"Haussinger","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2009.03.009_bib4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2165\/00003495-200060060-00008","article-title":"Hepatic encephalopathy in liver cirrhosis: pathogenesis, diagnosis and management","volume":"60","author":"Gerber","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.mcna.2009.03.009_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0168-8278(00)80424-9","article-title":"Complications of cirrhosis III. Hepatic encephalopathy","volume":"32","author":"Butterworth","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0404.1977.tb05623.x","article-title":"Number of Purkinje cells and Bergmann astrocytes in rats with CCl4-induced liver disease","volume":"55","author":"Diemer","year":"1977","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.mcna.2009.03.009_bib7","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/path.1711400403","article-title":"The brain in experimental portal-systemic encephalopathy. I. Morphological changes in three animal models","volume":"140","author":"Pilbeam","year":"1983","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.mcna.2009.03.009_bib8","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/hep.21357","article-title":"Glutamine: a Trojan horse in ammonia neurotoxicity","volume":"44","author":"Albrecht","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0197-0186(02)00030-X","article-title":"Chronic hyperammonemia alters protein phosphorylation and glutamate receptor-associated signal transduction in brain","volume":"41","author":"Corbalan","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mcna.2009.03.009_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1096\/fj.01-0862fje","article-title":"Ammonia induces MK-801-sensitive nitration and phosphorylation of protein tyrosine residues in rat astrocytes","volume":"16","author":"Schliess","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.mcna.2009.03.009_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/glia.20019","article-title":"Hypoosmotic swelling increases protein tyrosine nitration in cultured rat astrocytes","volume":"47","author":"Schliess","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.mcna.2009.03.009_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/jnr.1222","article-title":"Ammonia-induced production of free radicals in primary cultures of rat astrocytes","volume":"66","author":"Murthy","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/glia.20003","article-title":"Glutamine-induced free radical production in cultured astrocytes","volume":"46","author":"Jayakumar","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.mcna.2009.03.009_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/jnr.10755","article-title":"Suppression of ammonia-induced astrocyte swelling by cyclosporin A","volume":"74","author":"Rama Rao","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib15","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11011-007-9063-4","article-title":"Aquaporin-4 in hepatic encephalopathy","volume":"22","author":"Rama Rao","year":"2007","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.nbd.2006.04.006","article-title":"Taurine rescues hippocampal long-term potentiation from ammonia-induced impairment","volume":"23","author":"Chepkova","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1021978618745","article-title":"Oral amino acid load mimicking hemoglobin results in reduced regional cerebral perfusion and deterioration in memory tests in patients with cirrhosis of the liver","volume":"18","author":"Jalan","year":"2003","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/jcbfm.1991.67","article-title":"Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy","volume":"11","author":"Lockwood","year":"1991","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.mcna.2009.03.009_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1023\/B:MEBR.0000043976.17500.8e","article-title":"Functional imaging of the brain in patients with liver cirrhosis","volume":"19","author":"Weissenborn","year":"2004","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib20","first-page":"1324","article-title":"Reversal of hepatic coma by benzodiazepine antagonists (Ro 15-1788)","volume":"1","author":"Bansky","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S0140-6736(85)92809-0","article-title":"Reversal of hepatic coma by benzodiazepine antagonist (Ro 15-1788)","volume":"1","author":"Scollo-Lavizzari","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.hepres.2003.11.005","article-title":"Endotoxinemia and benzodiazepine-like substances in compensated cirrhotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparation","volume":"28","author":"Lighthouse","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1080\/00365529850170919","article-title":"Benzodiazepine-like compounds in the plasma of patients with fulminant hepatic failure","volume":"33","author":"Zeneroli","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1006\/phrs.1997.0198","article-title":"Antibacterial activity of rifaximin reduces the levels of benzodiazepine-like compounds in patients with liver cirrhosis","volume":"35","author":"Zeneroli","year":"1997","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.1840200241","article-title":"The involvement of benzodiazepine receptor ligands in hepatic encephalopathy","volume":"20","author":"Basile","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1542-3565(04)00531-2","article-title":"Neuroimaging in hepatic encephalopathy","volume":"3","author":"Stewart","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib27","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2005.075051","article-title":"In vivo imaging of cerebral \u201cperipheral benzodiazepine binding sites\u201d in patients with hepatic encephalopathy","volume":"55","author":"Cagnin","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2009.03.009_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/ana.20534","article-title":"Increased brain concentrations of a neuroinhibitory steroid in human hepatic encephalopathy","volume":"58","author":"Ahboucha","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mcna.2009.03.009_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/cs0670167","article-title":"Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist","volume":"67","author":"Baraldi","year":"1984","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.mcna.2009.03.009_bib30","first-page":"870","article-title":"Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure","volume":"102","author":"Schafer","year":"1983","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib31","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.1840080517","article-title":"Affinities and densities of high-affinity [3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy","volume":"8","author":"Butterworth","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0197-0186(03)00065-2","article-title":"Normal coupling of brain benzodiazepine and neurosteroid modulatory sites on the GABA-A receptor complex in human hepatic encephalopathy","volume":"43","author":"Ahboucha","year":"2003","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mcna.2009.03.009_bib33","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1471-4159.1992.tb08467.x","article-title":"Amino acid neurotransmitter receptor changes in cerebral cortex in alcoholism: effect of cirrhosis of the liver","volume":"59","author":"Dodd","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.mcna.2009.03.009_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jhep.2003.12.007","article-title":"Infection, inflammation and hepatic encephalopathy, synergism redefined","volume":"40","author":"Blei","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib35","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/jhep.2000.17687","article-title":"The systemic inflammatory response syndrome in acute liver failure","volume":"32","author":"Rolando","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib36","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0016-5085(03)01051-5","article-title":"Infection and the progression of hepatic encephalopathy in acute liver failure","volume":"125","author":"Vaquero","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuint.2005.04.008","article-title":"Astrocyte swelling and protein tyrosine nitration in hepatic encephalopathy","volume":"47","author":"Haussinger","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mcna.2009.03.009_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2007.03.026","article-title":"Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital","volume":"47","author":"Pedersen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jhep.2003.10.016","article-title":"Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis","volume":"40","author":"Shawcross","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0197-0186(02)00013-X","article-title":"Astrocytes and manganese neurotoxicity","volume":"41","author":"Hazell","year":"2002","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mcna.2009.03.009_bib41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0197-0186(99)00024-8","article-title":"Increased expression of glyceraldehyde-3-phosphate dehydrogenase in cultured astrocytes following exposure to manganese","volume":"35","author":"Hazell","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mcna.2009.03.009_bib42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00489-9","article-title":"Chronic exposure of rat primary astrocyte cultures to manganese results in increased binding sites for the \u2018peripheral-type\u2019 benzodiazepine receptor ligand 3H-PK 11195","volume":"271","author":"Hazell","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mcna.2009.03.009_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0140-6736(95)92164-8","article-title":"Manganese and chronic hepatic encephalopathy","volume":"346","author":"Krieger","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib44","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/hep.510240523","article-title":"Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms","volume":"24","author":"Spahr","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF02081027","article-title":"Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation","volume":"10","author":"Weissenborn","year":"1995","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib46","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0016-5085(99)70457-9","article-title":"Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction","volume":"117","author":"Rose","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib47","first-page":"198","article-title":"The neurological disorder associated with liver disease","volume":"32","author":"Adams","year":"1953","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1212\/01.WNL.0000078816.05164.B1","article-title":"Mini-asterixis in hepatic encephalopathy induced by pathologic thalamo-motor-cortical coupling","volume":"61","author":"Timmermann","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2009.03.009_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0168-8278(02)00423-3","article-title":"Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation","volume":"38","author":"Joebges","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000117040","article-title":"Hepatic myelopathy: a rare complication of portacaval shunt","volume":"34","author":"Mendoza","year":"1994","journal-title":"Eur Neurol"},{"key":"10.1016\/j.mcna.2009.03.009_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/A:1011610427843","article-title":"Quality of life in cirrhotics with minimal hepatic encephalopathy","volume":"16","author":"Schomerus","year":"2001","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0168-8278(01)00026-5","article-title":"Neuropsychological characterization of hepatic encephalopathy","volume":"34","author":"Weissenborn","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib53","series-title":"Textbook of neuropsychiatry and clinical neurosciences","article-title":"The neuropsychological evaluation","author":"Howieson","year":"2002"},{"key":"10.1016\/j.mcna.2009.03.009_bib54","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1001\/archneur.1996.00550080076015","article-title":"Neuropsychological characterization and detection of subclinical hepatic encephalopathy","volume":"53","author":"McCrea","year":"1996","journal-title":"Arch Neurol"},{"issue":"Suppl 19","key":"10.1016\/j.mcna.2009.03.009_bib55","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1097\/01.aids.0000192076.03443.6d","article-title":"Neurological and neuropsychiatric syndromes associated with liver disease","volume":"3","author":"Weissenborn","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.mcna.2009.03.009_bib56","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/hep.21586","article-title":"Value of the critical flicker frequency in patients with minimal hepatic encephalopathy","volume":"45","author":"Romero-Gomez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2007.02.022","article-title":"Critical flicker frequency: diagnostic tool for minimal hepatic encephalopathy","volume":"47","author":"Sharma","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib58","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/0140-6736(91)92920-W","article-title":"Regional cerebral blood flow and cognitive function in patients with chronic liver disease","volume":"337","author":"O'Carroll","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib59","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0033-3182(94)71759-X","article-title":"The neuropathogenesis of delirium. A need to focus our research","volume":"35","author":"Trzepacz","year":"1994","journal-title":"Psychosomatics"},{"key":"10.1016\/j.mcna.2009.03.009_bib60","first-page":"405","article-title":"Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy","volume":"41","author":"Catafau","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib61","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1020680624084","article-title":"Cerebral magnetic resonance imaging in patients with chronic liver disease","volume":"13","author":"Morgan","year":"1998","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib62","first-page":"647","article-title":"Iron and manganese homeostasis in chronic liver disease: relationship to pallidal T1-weighted magnetic resonance signal hyperintensity","volume":"20","author":"Malecki","year":"1999","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.mcna.2009.03.009_bib63","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/gut.2006.110569","article-title":"Correlations between magnetic resonance spectroscopy alterations and cerebral ammonia and glucose metabolism in cirrhotic patients with and without hepatic encephalopathy","volume":"56","author":"Weissenborn","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2009.03.009_bib64","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/hep.21114","article-title":"Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy","volume":"43","author":"Kale","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib65","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02081029","article-title":"Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability","volume":"10","author":"Watanabe","year":"1995","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib66","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/hep.20095","article-title":"Minimal hepatic encephalopathy impairs fitness to drive","volume":"39","author":"Wein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0168-8278(95)80325-4","article-title":"Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage","volume":"23","author":"Jalan","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib68","first-page":"46","article-title":"Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study","volume":"20","author":"Sanyal","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib69","first-page":"549","article-title":"Hepatic encephalopathy after transjugular intrahepatic portosystemic shunts: incidence and risk factors","volume":"90","author":"Somberg","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib70","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","article-title":"Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings","volume":"114","author":"Casado","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib71","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.510280508","article-title":"Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations","volume":"28","author":"Nolte","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib72","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gut.2005.089482","article-title":"Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy","volume":"55","author":"Kochar","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2009.03.009_bib73","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJM195208142470703","article-title":"The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances","volume":"247","author":"Phillips","year":"1952","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM195410212511702","article-title":"Dietary protein in the genesis of hepatic coma","volume":"251","author":"Schwartz","year":"1954","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib75","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(88)91033-1","article-title":"New mode of action for lactulose","volume":"1","author":"van Leeuwen","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib77","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0140-6736(05)66366-0","article-title":"Treatment of hepatic encephalopathy","volume":"365","author":"Cordoba","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib78","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/hep.1840070404","article-title":"Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind, randomized clinical trial","volume":"7","author":"Uribe","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib79","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1002\/hep.1840070617","article-title":"Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial","volume":"7","author":"Morgan","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib80","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0168-8278(89)90009-3","article-title":"Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study","volume":"8","author":"Morgan","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.21533","article-title":"Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy","volume":"45","author":"Prasad","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib82","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1136\/bmj.38048.506134.EE","article-title":"Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials","volume":"328","author":"Als-Nielsen","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2009.03.009_bib83","first-page":"542","article-title":"Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy","volume":"39","author":"Strauss","year":"1992","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib84","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF01072921","article-title":"Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial","volume":"23","author":"Atterbury","year":"1978","journal-title":"Am J Dig Dis"},{"key":"10.1016\/j.mcna.2009.03.009_bib85","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(77)80135-2","article-title":"Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial","volume":"72","author":"Conn","year":"1977","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib86","first-page":"1063","volume":"18","author":"Blanc","year":"1994","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.mcna.2009.03.009_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/gut.23.1.1","article-title":"Treatment of hepatic encephalopathy with metronidazole","volume":"23","author":"Morgan","year":"1982","journal-title":"Gut"},{"key":"10.1016\/j.mcna.2009.03.009_bib88","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-4615-1989-8_13","article-title":"Neomycin reduces the intestinal production of ammonia from glutamine","volume":"368","author":"Hawkins","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mcna.2009.03.009_bib89","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/0002-9343(79)90649-1","article-title":"Drugs, alcohol and malabsorption","volume":"67","author":"Green","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib90","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0168-8278(99)80144-5","article-title":"Prognostic significance of hepatic encephalopathy in patients with cirrhosis","volume":"30","author":"Bustamante","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib91","first-page":"646A","article-title":"Rifaximin treatment is beneficial for mild hepatic encephalopathy","volume":"40","author":"Bass","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib92","first-page":"175","article-title":"Rifaximin versus neomycin on hyperammoniemia in chronic portal systemic encephalopathy of cirrhotics. A double-blind, randomized trial","volume":"23","author":"Pedretti","year":"1991","journal-title":"Ital J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib93","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8278(02)00350-1","article-title":"Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial","volume":"38","author":"Mas","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib94","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00042737-200012020-00012","article-title":"Evaluation of the efficacy and safety of rifaximin in the treatment of hepatic encephalopathy: a double-blind, randomized, dose-finding multi-centre study","volume":"12","author":"Williams","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib95","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1185\/03007999309111539","article-title":"Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy","volume":"13","author":"Bucci","year":"1993","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mcna.2009.03.009_bib96","first-page":"57","article-title":"Rifaximin in the treatment of hepatic encephalopathy","volume":"4","author":"Giacomo","year":"1993","journal-title":"Eur J Clin Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib97","first-page":"7","article-title":"Treatment of hepatic encephalopathy with rifaximin: double blind, double dummy study versus lactulose","volume":"4","author":"Massa","year":"1993","journal-title":"Eur J Clin Res"},{"key":"10.1016\/j.mcna.2009.03.009_bib98","first-page":"E203","article-title":"Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats","volume":"235","author":"Rabbani","year":"1978","journal-title":"Am J Physiol"},{"key":"10.1016\/j.mcna.2009.03.009_bib99","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.1840160326","article-title":"Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis","volume":"16","author":"Riggio","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-89-4-483","article-title":"Experimental zinc deficiency in humans","volume":"89","author":"Prasad","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib101","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(84)92567-4","article-title":"Oral zinc supplementation improves hepatic encephalopathy. Results of a randomised controlled trial","volume":"2","author":"Reding","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2009.03.009_bib102","first-page":"731","article-title":"Correlations between zinc, amino acids and ammonia in liver cirrhosis","volume":"27","author":"Grungreiff","year":"1989","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib103","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/hep.510230523","article-title":"Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis","volume":"23","author":"Marchesini","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib104","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/BF01307509","article-title":"Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind crossover trial","volume":"36","author":"Riggio","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2009.03.009_bib105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3810\/pgm.2001.02.850","article-title":"Hepatic encephalopathy. Metabolic consequence of cirrhosis often is reversible","volume":"109","author":"Abou-Assi","year":"2001","journal-title":"Postgrad Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib106","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.1840160123","article-title":"Sodium benzoate in the treatment of acute hepatic encephalopathy: a double-blind randomized trial","volume":"16","author":"Sushma","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib107","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1572-0241.2001.03964.x","article-title":"Hepatic encephalopathy","volume":"96","author":"Blei","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib108","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/0016-5085(79)90399-8","article-title":"Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial","volume":"76","author":"Uribe","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mcna.2009.03.009_bib109","first-page":"32","article-title":"Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial","volume":"19","author":"Pomier-Layrargues","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/hep.510280212","article-title":"Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study","volume":"28","author":"Barbaro","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib111","first-page":"118","article-title":"The efficacy of flumazenil in subclinical to mild hepatic encephalopathic ambulatory patients. A prospective, randomised, double-blind, placebo-controlled study","volume":"133","author":"Dursun","year":"2003","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.mcna.2009.03.009_bib112","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/hep.510250609","article-title":"Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study","volume":"25","author":"Kircheis","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib113","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0168-8278(98)80237-7","article-title":"Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study","volume":"28","author":"Stauch","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib114","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3748\/wjg.v11.i45.7197","article-title":"Effects of L-carnitine in patients with hepatic encephalopathy","volume":"11","author":"Malaguarnera","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib115","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-1-4684-5826-8_13","article-title":"Effect of L-carnitine upon ammonia tolerance test in cirrhotic patients","volume":"272","author":"del Olmo","year":"1990","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.mcna.2009.03.009_bib116","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1542-3565(04)00667-6","article-title":"A randomized controlled trial of acarbose in hepatic encephalopathy","volume":"3","author":"Gentile","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib117","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-9877(03)00192-0","article-title":"Probiotics can treat hepatic encephalopathy","volume":"61","author":"Solga","year":"2003","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mcna.2009.03.009_bib118","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.mehy.2004.07.029","article-title":"Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy","volume":"64","author":"Bongaerts","year":"2005","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mcna.2009.03.009_bib119","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/hep.20194","article-title":"Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis","volume":"39","author":"Liu","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0168-8278(95)80309-2","article-title":"Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy","volume":"23","author":"Loguercio","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib121","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1007\/s10620-006-9687-y","article-title":"Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study","volume":"52","author":"Malaguarnera","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.mcna.2009.03.009_bib122","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1572-0241.2008.01861.x","article-title":"Probiotic yogurt for the treatment of minimal hepatic encephalopathy","volume":"103","author":"Bajaj","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.mcna.2009.03.009_bib123","doi-asserted-by":"crossref","first-page":"295S","DOI":"10.1093\/jn\/136.1.295S","article-title":"Branched-chain amino acid enriched supplements as therapy for liver disease","volume":"136","author":"Charlton","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/j.mcna.2009.03.009_bib124","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.clnu.2006.01.018","article-title":"ESPEN guidelines on enteral nutrition: liver disease","volume":"25","author":"Plauth","year":"2006","journal-title":"Clin Nutr"},{"key":"10.1016\/j.mcna.2009.03.009_bib125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jhep.2004.03.023","article-title":"Normal protein diet for episodic hepatic encephalopathy: results of a randomized study","volume":"41","author":"Cordoba","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib126","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1079\/BJN19950158","article-title":"Long-term oral refeeding of patients with cirrhosis of the liver","volume":"74","author":"Nielsen","year":"1995","journal-title":"Br J Nutr"},{"key":"10.1016\/j.mcna.2009.03.009_bib127","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/01.meg.0000059162.46867.f0","article-title":"Improvement of regional cerebral blood flow after treatment with branched-chain amino acid solutions in patients with cirrhosis","volume":"15","author":"Iwasa","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib128","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis","volume":"3","author":"Muto","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib129","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001939","article-title":"Branched-chain amino acids for hepatic encephalopathy","volume":"2","author":"Als-Nielsen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mcna.2009.03.009_bib130","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/lt.20236","article-title":"Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study","volume":"10","author":"Sen","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.mcna.2009.03.009_bib131","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1053\/jhep.2002.36130","article-title":"Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study","volume":"36","author":"Heemann","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib132","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/hep.21930","article-title":"Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis","volume":"46","author":"Hassanein","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.mcna.2009.03.009_bib133","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2005.02.038","article-title":"In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation","volume":"43","author":"Krisper","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.mcna.2009.03.009_bib134","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/00003246-200107000-00006","article-title":"Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure","volume":"29","author":"Sorkine","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib135","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1525-1594.1999.06122.x","article-title":"Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support","volume":"23","author":"Stange","year":"1999","journal-title":"Artif Organs"},{"key":"10.1016\/j.mcna.2009.03.009_bib136","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/01.CCM.0000196203.39832.3C","article-title":"Effect of albumin dialysis on intracranial pressure increase in pigs with acute liver failure: a randomized study","volume":"34","author":"Sen","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.mcna.2009.03.009_bib137","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/039139889601901109","article-title":"A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver","volume":"19","author":"Stange","year":"1996","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.mcna.2009.03.009_bib138","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1023\/A:1021986624600","article-title":"Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS \u2013 a review of clinical, biochemical, and electrophysiological data","volume":"17","author":"Mitzner","year":"2002","journal-title":"Metab Brain Dis"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712509000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712509000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T06:27:09Z","timestamp":1589956029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712509000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":138,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0025712509000406"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2009.03.009","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}